(Q34079347)

English

ErbB2 and NFκB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

ErbB2 and NFκB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer (English)

1 reference

Europe PubMed Central

30 July 2017

chemoradiotherapy

0 references

7

object named as

Len Neckers

1 reference

Europe PubMed Central

30 July 2017

author name string

Fumitaka Koga

1

1 reference

Europe PubMed Central

30 July 2017

Soichiro Yoshida

2

1 reference

Europe PubMed Central

30 July 2017

Manabu Tatokoro

3

1 reference

Europe PubMed Central

30 July 2017

Satoru Kawakami

4

1 reference

Europe PubMed Central

30 July 2017

Yasuhisa Fujii

5

1 reference

Europe PubMed Central

30 July 2017

Jiro Kumagai

6

1 reference

Europe PubMed Central

30 July 2017

Kazunori Kihara

8

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

10 November 2011

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

6

1 reference

Europe PubMed Central

30 July 2017

11

1 reference

Europe PubMed Central

30 July 2017

e27616

1 reference

Europe PubMed Central

30 July 2017

copyright license

Creative Commons CC0 License

10 November 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Excision repair cross-complementing group 1 may predict the efficacy of chemoradiation therapy for muscle-invasive bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Targeting the dynamic HSP90 complex in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Current status of radiation therapy for bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Trimodality treatment and selective organ preservation for bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Signal transduction and oncogenesis by ErbB/HER receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Overview of bladder cancer trials in the Radiation Therapy Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

The natural history of bladder cancer. Implications for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Deoxyribonucleic acid flow cytometry in predicting response to radical radiotherapy of bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

5 July 2018

Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

28 October 2018

Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

28 October 2018

Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

28 October 2018

Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213163

28 October 2018

Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of Ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis in carcinoma of the bladder: relation with radiation treatment results

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22102915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0027616

1 reference

Europe PubMed Central

30 July 2017

2011PLoSO...627616K

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34079347&oldid=1868628169"